These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17338595)

  • 1. Tramadol extended-release tablets in moderate to moderately severe chronic pain in adults: profile report.
    Hair PI; Curran MP; Keam SJ
    CNS Drugs; 2007; 21(3):259-63. PubMed ID: 17338595
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain.
    Barkin RL
    Am J Ther; 2008; 15(2):157-66. PubMed ID: 18356636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tramadol extended-release tablets.
    Hair PI; Curran MP; Keam SJ
    Drugs; 2006; 66(15):2017-27; discussion 2028-30. PubMed ID: 17100415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another once-daily formulation of tramadol (Ryzolt).
    Med Lett Drugs Ther; 2010 May; 52(1338):39-40. PubMed ID: 20467357
    [No Abstract]   [Full Text] [Related]  

  • 5. Extended-release formulations of tramadol in the treatment of chronic pain.
    Pergolizzi JV; Taylor R; Raffa RB
    Expert Opin Pharmacother; 2011 Aug; 12(11):1757-68. PubMed ID: 21609187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tramadol--the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of pain.
    Klotz U
    Arzneimittelforschung; 2003; 53(10):681-7. PubMed ID: 14650359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tramadol sustained-release capsules.
    Keating GM
    Drugs; 2006; 66(2):223-30. PubMed ID: 16451094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study.
    Likar R; Wittels M; Molnar M; Kager I; Ziervogel G; Sittl R
    Clin Ther; 2006 Dec; 28(12):2022-39. PubMed ID: 17296459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain.
    Pascual ML; Fleming RR; Gana TJ; Vorsanger GJ
    Curr Med Res Opin; 2007 Oct; 23(10):2531-42. PubMed ID: 17825129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Dose Pharmacokinetic Study of Tramadol Extended-Release Tablets in Children and Adolescents.
    Vandenbossche J; Van Peer A; Richards H
    Clin Pharmacol Drug Dev; 2016 Sep; 5(5):343-53. PubMed ID: 27138295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single- and multiple-dose pharmacokinetic studies of tramadol immediate-release tablets in children and adolescents.
    Vandenbossche J; Richards H; Solanki B; Van Peer A
    Clin Pharmacol Drug Dev; 2015; 4(3):184-92. PubMed ID: 27140798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-release hydrocodone (Zohydro) for pain.
    Med Lett Drugs Ther; 2014 Jun; 56(1444):45-6. PubMed ID: 24933087
    [No Abstract]   [Full Text] [Related]  

  • 14. A morphine/naltrexone combination (Embeda) for pain.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules.
    Bodalia B; McDonald CJ; Smith KJ; O'Brien C; Cousens L
    J Pain Symptom Manage; 2003 Feb; 25(2):142-9. PubMed ID: 12590030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of tramadol in children.
    Bozkurt P
    Paediatr Anaesth; 2005 Dec; 15(12):1041-7. PubMed ID: 16324021
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of extended-release tramadol on pain-related sleep parameters in patients with osteoarthritis.
    Florete OG; Xiang J; Vorsanger GJ
    Expert Opin Pharmacother; 2008 Aug; 9(11):1817-27. PubMed ID: 18627321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of the biopharmaceutical properties of tramadol sustained-release formulations for chrono-pharmacologically optimized treatment of pain from various sources.
    Warnke A; Schug B; Vanderbist F; Erbist ; Blume H
    Int J Clin Pharmacol Ther; 2009 Jun; 47(6):405-12. PubMed ID: 19473603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects and assays of controlled-release tramadol and o-desmethyltramadol in cancer patients with pain.
    Leppert W; Mikolajczak P
    Curr Pharm Biotechnol; 2011 Feb; 12(2):306-12. PubMed ID: 21050160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA approves oxycodone and acetaminophen extended-release tablets.
    J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):188-9. PubMed ID: 25011144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.